Glenn Dale

Glenn Dale

Company: BioVersys

Job title: Chief Development Officer

Seminars:

BV100 – a Novel Therapy for Antibiotic-Resistant Acinetobacter Infections 11:15 am

Read more

day: Day Two

Q&A/Discussion 12:30 pm

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.